J, S., Y, X., Q, Z., J, C., W, Z., H, Z., & Y, D. (2025). Astragaloside IV Attenuates Chronic Prostatitis by Activating Keap1/Nrf2/HO-1 Pathway: Suppressing Ferroptosis and Enhancing Antioxidant Defense. Dove Medical Press.
Chicago Style (17th ed.) CitationJ, Shi, Xuan Y, Zhang Q, Chen J, Zhu W, Zhang H, and Duan Y. Astragaloside IV Attenuates Chronic Prostatitis by Activating Keap1/Nrf2/HO-1 Pathway: Suppressing Ferroptosis and Enhancing Antioxidant Defense. Dove Medical Press, 2025.
MLA (9th ed.) CitationJ, Shi, et al. Astragaloside IV Attenuates Chronic Prostatitis by Activating Keap1/Nrf2/HO-1 Pathway: Suppressing Ferroptosis and Enhancing Antioxidant Defense. Dove Medical Press, 2025.
Warning: These citations may not always be 100% accurate.